Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cv Sciences Inc (CVSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 537,485
  • Shares Outstanding, K 96,670
  • Annual Sales, $ 48,240 K
  • Annual Income, $ 10,000 K
  • 60-Month Beta -0.72
  • Price/Sales 11.10
  • Price/Cash Flow 50.28
  • Price/Book 17.65
  • Price/Earnings ttm 55.40
  • Earnings Per Share ttm 0.10
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.02
  • Number of Estimates 1
  • High Estimate 0.02
  • Low Estimate 0.02
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.7100 +18.05%
on 03/19/19
6.5900 -15.63%
on 03/26/19
+0.8500 (+18.05%)
since 03/18/19
3-Month
4.3300 +28.41%
on 03/08/19
6.5900 -15.63%
on 03/26/19
+1.1800 (+26.94%)
since 01/18/19
52-Week
0.5600 +892.86%
on 04/19/18
9.2000 -39.57%
on 08/20/18
+5.0000 (+892.86%)
since 04/18/18

Most Recent Stories

More News
CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor

CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp CBD products, announced that it has appointed Deloitte & Touche LLP ("Deloitte")...

CVSI : 5.5600 (+0.36%)
Cannabis Market Brief: Growing Number of Retailers Adding CBD Infused Products as Revenues Jump

Recent predictions for the CBD infused products market have created much enthusiasm and the optimists not only see the glass as half full… but they see it as overflowing! The predictions by the Brightfield...

KSHB : 5.4950 (+1.20%)
CVSI : 5.5600 (+0.36%)
POTND : 0.0200 (+32.45%)
MRMD : 3.4920 (-0.51%)
LBUY : 1.0550 (+1.93%)
POTN : 0.1394 (+0.29%)
CV Sciences, Inc. Announces Distribution Expansion Into Food, Drug and Mass Channels

CV Sciences, Inc.(OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp CBD products, is pleased to announce further expansion of its industry-dominating...

CVSI : 5.5600 (+0.36%)
CBD Industry set to Explode as New Products, Consumers Enter Market

The U.S. Farm Bill that recently passed into law is a game-changer for the CBD space. While it is unknown when nationwide cannabis legalization may occur, incredible opportunities exist right now for CBD-focused...

CURLF : 10.4300 (+4.13%)
ISOLF : 0.9975 (+0.76%)
GWPRF : 12.6900 (-4.23%)
CVSI : 5.5600 (+0.36%)
ISOL.CN : 1.330 (+1.53%)
CURA.CN : 13.930 (+4.34%)
YGYI : 5.50 (+0.73%)
GWPH : 155.87 (+0.08%)
CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer

CV Sciences, Inc.(OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating brand, PlusCBD Oil(TM), announced...

CVSI : 5.5600 (+0.36%)
STZ : 198.80 (+3.77%)
Farm Bill Passing Opens up Ancillary Markets for CBD Sector

Last year was a banner year for cannabis, as California became the largest legal US marketplace, Canada rolled out broad legalization, and Mexico's Supreme Court opened the door to being the next country...

GTII.CN : 21.040 (+7.02%)
CVSI : 5.5600 (+0.36%)
NXTTF : 0.4084 (-8.25%)
TRTC : 0.8775 (+15.84%)
N.VN : 0.550 (-5.17%)
GTBIF : 15.5949 (+5.82%)
CNNA.CN : 0.620 (+3.33%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.8023 (+2.86%)
TRLFF : 0.3287 (+1.11%)
AITB : 4.6500 (-2.72%)
BICXD : 4.5400 (-9.02%)
MMNFF : 3.0200 (+1.20%)
ATEA : 6.2100 (+0.16%)
CWBHF : 20.4495 (-2.21%)
CVSI : 5.5600 (+0.36%)
DUOT : 0.7200 (-10.00%)
CRLBF : 12.0933 (-0.95%)
ARREF : 0.7100 (-3.68%)
CLOK : 0.9300 (unch)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.3600 (-1.37%)
HEOFF : 0.6210 (+0.16%)
MJARF : 1.8700 (+2.19%)
ALEAF : 1.3395 (+8.90%)
OTCM : 33.5000 (+2.29%)
NUPMF : 1.7195 (-2.85%)
GLDLF : 0.6842 (+0.01%)
NMUS : 0.6500 (-9.52%)
NLST : 0.4000 (-2.44%)
GBPT : 0.2500 (+8.70%)
IMLFF : 0.3688 (-4.11%)
KSHB : 5.4950 (+1.20%)
CORVF : 1.4100 (-2.81%)
ELLXF : 3.7600 (-1.83%)
RSSS : 2.2400 (+6.67%)
ISYRF : 1.0130 (-6.70%)
FLUX : 1.3100 (-0.76%)
NWGI : 0.3500 (+6.06%)
QBIO : 1.8300 (-1.08%)
WIZD : 0.1700 (unch)
MRMD : 3.4920 (-0.51%)
GRWG : 2.9900 (unch)
BRTI : 0.2200 (+10.00%)
GTBP : 0.3850 (+13.24%)
MRIC : 2.8400 (-4.70%)
DYAI : 3.55 (+4.41%)
GTBIF : 15.5949 (+5.82%)
MTAFF : 0.8300 (-4.75%)
EMHTF : 2.7744 (-2.31%)
ITHUF : 5.1200 (+2.94%)
ALYE : 2.0000 (-20.00%)
VTLR : 0.1411 (-5.93%)
ARHH : 1.2500 (-7.41%)
OWCP : 0.0250 (-1.96%)
STLHF : 0.6766 (-1.18%)
PPCB : 0.0100 (+2.04%)
ARTH : 0.3645 (+1.25%)
ACRGF : 22.5100 (+0.76%)
CV Sciences, Inc. Reports Fiscal Year-End 2018 Financial Results

Record full year revenue

CVSI : 5.5600 (+0.36%)
CV Sciences, Inc. Appoints Dr. Douglas MacKay as Senior Vice President of Scientific and Regulatory Affairs

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of industry-dominating hemp CBD brand, PlusCBD Oil(TM), today announced the appointment...

CVSI : 5.5600 (+0.36%)
Rise in New CBD Products Resulting in Increase in Patent Filings

It seems like every day a new product enters the ever growing universe of CBD infused items. "Infusions" are appearing in restaurants, cookies, candy, pet foods, ice cream, gummies, olive oil, coffee,...

XLY.VN : 0.820 (+1.23%)
WEED.TO : 59.64 (+4.43%)
CBWTF : 0.6228 (+1.43%)
CVSI : 5.5600 (+0.36%)
KGKG : 0.0778 (+1.43%)
MCOA : 0.0136 (-1.45%)
CGC : 44.56 (+3.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade CVSI with:

Key Turning Points

2nd Resistance Point 5.7200
1st Resistance Point 5.6400
Last Price 5.5600
1st Support Level 5.4700
2nd Support Level 5.3800

See More

52-Week High 9.2000
Fibonacci 61.8% 5.8995
Last Price 5.5600
Fibonacci 50% 4.8800
Fibonacci 38.2% 3.8605
52-Week Low 0.5600

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar